Idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the scarring of lung tissue, which leads to difficulties in breathing. Common symptoms include a persistent dry cough, shortness of breath, particularly during physical activity, and fatigue. As the condition advances, these symptoms can worsen, significantly affecting daily life.
Treatment options for IPF primarily focus on managing symptoms and slowing disease progression. Antifibrotic medications, such as pirfenidone and nintedanib, are often prescribed to help reduce lung scarring. In addition, supportive therapies, including pulmonary rehabilitation and oxygen therapy, can enhance quality of life. In severe cases, a lung transplant may be considered.
The outlook for individuals with IPF varies. While the disease can progress rapidly in some patients, others may experience a slower decline. Regular follow-ups with healthcare professionals are crucial for monitoring the condition and adjusting treatment as needed. Early diagnosis and intervention can improve outcomes and help manage symptoms effectively.